Inventor · disambiguated record
Rumana Rashid
Also filed as: RASHID RUMANA
55 granted patents·23 pending applications·516 citations·filing 2012–2025
98Inventor score
Top patents by PatentIndex Score
78 records- 0199US9605084B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted Mar 28, 2017·74 cites·16 claims
- 0298US10550185B2Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragmentsXENCOR INC·Filed 2017·Granted Feb 4, 2020·29 cites·13 claims
- 0398US10501543B2IL15/IL15Rα heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2017·Granted Dec 10, 2019·13 cites·6 claims
- 0498US10259887B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2016·Granted Apr 16, 2019·25 cites·25 claims
- 0598US9856327B2Heterodimeric antibodies to CD3 X CD123XENCOR INC·Filed 2016·Granted Jan 2, 2018·72 cites·5 claims
- 0698US9701759B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted Jul 11, 2017·48 cites·8 claims
- 0798US9650446B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted May 16, 2017·44 cites·9 claims
- 0897US11472890B2Heterodimeric antibodies that bind ENPP3 and CD3XENCOR INC·Filed 2020·Granted Oct 18, 2022·9 cites·4 claims
- 0997US11225528B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2019·Granted Jan 18, 2022·11 cites·13 claims
- 1097US10526417B2Heterodimeric antibodies that bind CD3 and CD38XENCOR INC·Filed 2015·Granted Jan 7, 2020·27 cites·15 claims
- 1196US11358999B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2019·Granted Jun 14, 2022·12 cites·2 claims
- 1296US10738133B2Heterodimeric proteinsXENCOR INC·Filed 2017·Granted Aug 11, 2020·9 cites·7 claims
- 1395US12509495B2LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and LAG-3 antigen binding domainsXENCOR INC·Filed 2023·Granted Dec 30, 2025·1 cites·5 claims
- 1495US11655277B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2022·Granted May 23, 2023·2 cites·1 claims
- 1595US11505595B2TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domainsXENCOR INC·Filed 2019·Granted Nov 22, 2022·9 cites·12 claims
- 1695US11225521B2Heterodimeric antibodies that bind somatostatin receptor 2XENCOR INC·Filed 2019·Granted Jan 18, 2022·11 cites·23 claims
- 1795US11053316B2Optimized antibody variable regionsXENCOR INC·Filed 2018·Granted Jul 6, 2021·7 cites·6 claims
- 1895US9850320B2Heterodimeric antibodies to CD3 X CD20XENCOR INC·Filed 2016·Granted Dec 26, 2017·13 cites·5 claims
- 1994US12239688B2IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereofXENCOR INC·Filed 2021·Granted Mar 4, 2025·2 cites·20 claims
- 2094US11851466B2Targeted IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2020·Granted Dec 26, 2023·3 cites·16 claims
- 2194US11319355B2Engineered IL-2 Fc fusion proteinsXENCOR INC·Filed 2018·Granted May 3, 2022·5 cites·5 claims
- 2294US10131710B2Optimized antibody variable regionsXENCOR INC·Filed 2014·Granted Nov 20, 2018·15 cites·18 claims
- 2393US11634506B2Heterodimeric proteinsXENCOR INC·Filed 2020·Granted Apr 25, 2023·2 cites·9 claims
- 2493US11377477B2PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereofXENCOR INC·Filed 2019·Granted Jul 5, 2022·7 cites·13 claims
- 2593US10738132B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted Aug 11, 2020·9 cites·15 claims
- 2692US11945880B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2021·Granted Apr 2, 2024·1 cites·13 claims
- 2792US11859011B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2021·Granted Jan 2, 2024·1 cites·2 claims
- 2892US10316088B2Heterodimeric antibodies that bind somatostatin receptor 2XENCOR INC·Filed 2017·Granted Jun 11, 2019·11 cites·4 claims
- 2991US11932675B2PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved propertiesGENENTECH INC·Filed 2020·Granted Mar 19, 2024·2 cites·15 claims
- 3091US11584794B2Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragmentsXENCOR INC·Filed 2019·Granted Feb 21, 2023·2 cites·9 claims
- 3191US11299554B2Heterodimeric proteinsXENCOR INC·Filed 2019·Granted Apr 12, 2022·3 cites·10 claims
- 3291US10858417B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted Dec 8, 2020·7 cites·23 claims
- 3390US11618776B2Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domainsXENCOR INC·Filed 2019·Granted Apr 4, 2023·4 cites·7 claims
- 3490US11524991B2PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereofXENCOR INC·Filed 2019·Granted Dec 13, 2022·5 cites·17 claims
- 3589US10106624B2Heterodimeric proteinsXENCOR INC·Filed 2014·Granted Oct 23, 2018·7 cites·6 claims
- 3688US12359002B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2023·Granted Jul 15, 2025·0 cites·2 claims
- 3788US11352442B2Heterodimeric antibodies that bind CD3 and CD38XENCOR INC·Filed 2019·Granted Jun 7, 2022·2 cites·19 claims
- 3888US10968276B2Optimized anti-CD3 variable regionsXENCOR INC·Filed 2014·Granted Apr 6, 2021·6 cites·18 claims
- 3988US2025109215A1Heterodimeric antibodies that bind cd3 and tumor antigensXENCOR INC·Filed 2024·Application pending·0 cites
- 4088US2025304724A1Heterodimeric antibodies that bind cd3 and tumor antigensXENCOR INC·Filed 2025·Application pending·0 cites
- 4187US2025034247A1Optimized antibody variable regionsXENCOR INC·Filed 2024·Application pending·0 cites
- 4287US2025109214A1Heterodimeric antibodies that bind cd3 and cd38XENCOR INC·Filed 2024·Application pending·0 cites
- 4386US10889653B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2015·Granted Jan 12, 2021·2 cites·4 claims
- 4485US12415849B2Heterodimeric proteinsXENCOR INC·Filed 2023·Granted Sep 16, 2025·0 cites·11 claims
- 4584US10913803B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2018·Granted Feb 9, 2021·1 cites·11 claims
- 4684US2025092108A1ENGINEERED IL-2 Fc FUSION PROTEINSXENCOR INC·Filed 2024·Application pending·0 cites
- 4784US2023279154A1Novel heterodimeric proteinsXENCOR INC·Filed 2023·Application pending·0 cites
- 4883US2023220081A1BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTSXENCOR INC·Filed 2022·Application pending·0 cites
- 4983US2023399401A1Optimized antibody variable regionsXENCOR INC·Filed 2023·Application pending·0 cites
- 5083US2025057919A1Il-15/il-15ra heterodimeric fc fusion proteins and uses thereofXENCOR INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rumana Rashid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →